上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
Resibufogenin (Synonyms: 酯蟾毒配基; Bufogenin; Recibufogenin) 纯度: 99.69%
酯蟾毒配基 (Resibufogenin) 是华蟾素的一种成分,具有抑制氧化应激及肿瘤再生的功能。
Resibufogenin Chemical Structure
CAS No. : 465-39-4
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
10 mM * 1 mL in DMSO | ¥1595 | In-stock | |
5 mg | ¥1450 | In-stock | |
10 mg | ¥2250 | In-stock | |
50 mg | ¥8100 | In-stock | |
100 mg | 询价 | ||
200 mg | 询价 |
* Please select Quantity before adding items.
Resibufogenin 相关产品
•相关化合物库:
- Covalent Screening Library Plus
- Natural Product Library Plus
- Bioactive Compound Library Plus
- Natural Product Library
- Anti-Cancer Compound Library
- Anti-Aging Compound Library
- Covalent Screening Library
- Lipid Compound Library
- Oxygen Sensing Compound Library
- Traditional Chinese Medicine Monomer Library
生物活性 |
Resibufogenin, a component of huachansu, has been shown to exhibit the anti-proliferative effect against cancer cells, and this may be attributed to the degradation of cyclin D1 caused by the activation of GSK-3β. IC50 Value: Target: In vitro: The effects of Resibufogenin on the outward delayed rectifier potassium current (IK) and outward transient potassium current (IA) in rat hippocampal neurons was investigated, and it inhibited both IK and IA, at 1 μM concentration RBG could alter some channel kinetics and gating properties of IK, such as steady-state activation and inactivation curves, open probability and time constants [1]. In vivo: Resibufogenin prevented evidence of oxidative stress in “preeclamptic” rats [2]. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
分子量 |
384.51 |
||||||||||||||||
Formula |
C24H32O4 |
||||||||||||||||
CAS 号 |
465-39-4 |
||||||||||||||||
中文名称 |
蟾力苏;酯蟾毒配基;布福吉宁 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
|
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 100 mg/mL (260.07 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务